Newsroom
September 25, 2020
Clues sought for why 1 in 5 pediatric cancer survivors develop heart failure. Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart […]
September 24, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.
September 21, 2020
In this interview, Ruben Mesa, MD, director of the Mays Cancer Center, shares highlights from his presentation on the role of JAK inhibitors in myelofibrosis during the first annual Texas Virtual MPN Workshop and Meeting. Read the story.
September 18, 2020
Ruben Mesa, MD, FACP, director of the Mays Cancer Center, was a guest on a panel during the Congressional Hispanic Caucus Institute’s 2020 Leadership Conference.
September 15, 2020
In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis. Watch the interview.
September 14, 2020
This news brief highlights the renewal of the Mays Cancer Center as an NCI-Designated Cancer Center. Read the story.